Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Peripheral Blood Stem Cells

Allogeneic hematopoietic transplantation of CD34+ selected cells from an HLA haplo-identical related donor. A long-term follow-up of 135 patients and a comparison of stem cell source between the bone marrow and the peripheral blood

Abstract

We studied the outcome of allogeneic transplants in 135 patients who received selected BM and/or PBSC CD34+ cells from HLA haplo-identical related donors. Donor engraftment was achieved in 108 of 128 evaluable transplants. Engraftment failure occurred more often in non-malignant than in malignant diseases (10 of 25 vs 17 of 103, P = 0.010). The CD34+ cell dose was associated with the speed of neutrophil and platelet recovery, but the cell source was not. Acute GVHD (grade II) developed in 21.0 ± 3.7%. Chronic GVHD occurred more frequently in malignancies than in non-malignancies (44.1 ± 7.6% vs 0.0%, P = 0.0075), and more in PBSC recipients than in BM recipients (53.6 ± 9.4% vs 17.4 ± 9.3%, P = 0.0054). Relapse rate was higher in high risk patients than in standard risk patients (78.7 ± 7.1% vs 22.1 ± 10.0%, P = 0.0001). Probabilities of disease-free survival (DFS) were 14.2 ± 3.5% in malignancies and 25.7 ± 9.2% in non-malignancies. Probabilities of DFS in standard and high risk patients were 39.4 ± 9.2% and 5.7 ± 2.8% (P = 0.0001). A high incidence of graft failure, infection and relapse was observed and resulted in high mortality. Bone Marrow Transplantation (2000) 26, 1281–1290.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Civin CI, Strauss LC, Brovall C et al. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells J Immunol 1984 133: 157–165

    CAS  PubMed  Google Scholar 

  2. Baum CM, Weissman IL, Tsukamoto AS et al. Isolation of a candidate human hematopoietic stem-cell population Proc Natl Acad Sci USA 1992 89: 2804–2808

    Article  CAS  Google Scholar 

  3. Berenson RJ, Andrews RG, Bensinger WI et al. Antigen CD34+ cells engraft lethally irradiated baboons J Clin Invest 1988 81: 951–955

    Article  CAS  Google Scholar 

  4. Andrews RG, Bryant EM, Bartelmez SH et al. CD34+ marrow cells, devoid of T and B lymphocyte, reconstitute stable lymphopoiesis and myelopoiesis in lethally irradiated allogeneic baboons Blood 1992 80: 1693–1701

    CAS  PubMed  Google Scholar 

  5. Berenson RJ, Bensinger WI, Hill RS et al. Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma Blood 1991 77: 1717–1722

    CAS  PubMed  Google Scholar 

  6. Link H, Arseniev L, Bahre O et al. Transplantation allogeneic of CD34+ blood cells Blood 1996 87: 4903–4909

    CAS  PubMed  Google Scholar 

  7. Yabe H, Yabe M, Hattori K et al. Successful engraftment of allogeneic CD34-enriched marrow cell transplantation from HLA-mismatched parental donors Bone Marrow Transplant 1996 17: 985–991

    CAS  PubMed  Google Scholar 

  8. Finke J, Brugger W, Bertz H et al. Allogeneic transplantation of positively selected peripheral blood CD34+ progenitor cells from matched related donors Bone Marrow Transplant 1996 18: 1081–1086

    CAS  PubMed  Google Scholar 

  9. Bensinger WI, Buckner CD, Shannon-Dorcy K et al. Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy Blood 1996 88: 4132–4138

    CAS  PubMed  Google Scholar 

  10. Urbano-Ispizua A, Rozman C, Martinez C et al. Rapid engraftment without significant graft-versus-host disease after allogeneic transplantation of CD34+ selected cells from peripheral blood Blood 1997 89: 3967–3973

    CAS  PubMed  Google Scholar 

  11. Yasui M, Okamura T, Nakano T et al. CD34+ progenitor cell transplantation from HLA-mismatched family members to 21 children with high risk disorders Blood 1997 90: 399b

    Google Scholar 

  12. Yasui M, Park YD, Okamura T et al. CD34+ progenitor cell transplantation from two HLA-mismatched healthy fathers to two infants with severe aplastic anemia Int J Hematol 1998 67: 15–22

    Article  CAS  Google Scholar 

  13. Matsuda Y, Hara J, Osugi Y et al. Allogeneic peripheral stem cell transplantation using positively selected CD34+ cells from HLA-mismatched donors Bone Marrow Transplant 1998 21: 355–360

    Article  CAS  Google Scholar 

  14. Urbano-Ispizua A, Solano C, Brunet S et al. Allogeneic transplantation of selected CD34+ cells from peripheral blood: experience of 62 cases using immunoadsorption or immunomagnetic technique Bone Marrow Transplant 1998 22: 519–525

    Article  CAS  Google Scholar 

  15. Aversa F, Tabilio A, Velardi A et al. Treatment of high-risk acute leukemia with T cell-depleted stem cells from related donors with one fully mismatched HLA haplotype New Engl J Med 1998 339: 1186–1193

    Article  CAS  Google Scholar 

  16. Cornelissen JJ, Fibbe WE, Schattenberg AVMB et al. A retrospective Dutch study comparing T cell-depleted allogeneic blood stem cell transplantation vs T cell-depleted allogeneic bone marrow transplantation Bone Marrow Transplant 1998 21: S66–S70

    PubMed  Google Scholar 

  17. Kawano Y, Takaue Y, Watanabe A et al. Partially mismatched pediatric transplants with allogeneic CD34(+) blood cells from a related donor Blood 1998 92: 3123–3130

    CAS  PubMed  Google Scholar 

  18. Viret F, Chabannon C, Aurran-Schleinitz T et al. Transplantation of allogeneic CD34+ blood cells in leukemia or lymphoma patients at high risk of GVHD Bone Marrow Transplant 1999 24: 225–227

    Article  CAS  Google Scholar 

  19. Lang P, Schumm M, Taylor G et al. Clinical scale isolation of highly purified peripheral CD34+ progenitors for autologous and allogeneic transplantation in children Bone Marrow Transplant 1999 24: 583–589

    Article  CAS  Google Scholar 

  20. Martin PJ, Hansen JA, Buchner CD et al. Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts Blood 1985 66: 664–672

    CAS  PubMed  Google Scholar 

  21. Verdonck LF, de Gast GC, van Heugten HG, Deccker A . A fixed low number of T cells in HLA-identical allogeneic bone marrow transplantation Blood 1990 75: 776–780

    CAS  PubMed  Google Scholar 

  22. Schattenberg A, de Witte T, Preijers F et al. Allogeneic bone marrow transplantation for leukemia with marrow grafts depleted of lymphocytes by counterflow centrifugation Blood 1990 75: 1356–1363

    CAS  PubMed  Google Scholar 

  23. Aversa F, Tabilio A, Terenzi A et al. Successful engraftment of T cell-depleted haploidentical ‘three-loci’ incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum Blood 1994 84: 3948–3955

    CAS  PubMed  Google Scholar 

  24. Patterson J, Prentice HG, Brenner MK et al. Graft failure following HLA-matched T-lymphocyte depleted bone marrow transplantation Br J Haematol 1986 63: 221–230

    Article  CAS  Google Scholar 

  25. Marmont A, Horowitz MM, Gale RP et al. T cell depletion of HLA-identical transplants in leukemia Blood 1991 78: 2120–2130

    CAS  PubMed  Google Scholar 

  26. Russell N, Gratwohl A, Schmitz N . The place of blood stem cells in allogeneic transplantation Br J Haematol 1996 93: 747–753

    Article  Google Scholar 

  27. Miflin G, Russell NH, Hutchinson RM et al. Allogeneic peripheral blood stem transplantation for haematological malignancies – an analysis of kinetics of engraftment and GVHD risk Bone Marrow Transplant 1997 19: 9–13

    Article  CAS  Google Scholar 

  28. Solano C, Martinez C, Brunet S et al. Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case–control study Bone Marrow Transplant 1998 22: 1129–1135

    Article  CAS  Google Scholar 

  29. Mahmoud HK, Fahmy OA, Kamel A et al. Peripheral blood vs bone marrow as a source for allogeneic hematopoietic stem cell transplantation Bone Marrow Transplant 1999 24: 355–358

    Article  CAS  Google Scholar 

  30. Ringden O, Remberger M, Runde V et al. Peripheral blood stem cell transplantation from unrelated donors: a comparison with marrow transplantation Blood 1999 94: 455–464

    CAS  PubMed  Google Scholar 

  31. Russell JA, Larratt L, Brown C et al. Allogeneic blood stem cell and bone marrow transplantation for acute myelogenous leukemia and myelodysplasia: influence of stem cell source on outcome Bone Marrow Transplant 1999 24: 1177–1183

    Article  CAS  Google Scholar 

  32. Rubinstein P, Carrier C, Scaradavou A et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors New Engl J Med 1998 339: 1565–1577

    Article  CAS  Google Scholar 

  33. Dreger P, Viehmann K, Steinmann J et al. G-CSF mobilized peripheral blood progenitor cells for allogeneic transplantation: comparison of T cell depletion strategies using different CD34+ selection systems or CAMPATH-1 Exp Hematol 1995 23: 147–154

    CAS  PubMed  Google Scholar 

  34. Przepiorka D, Smith T, Folloder J et al. Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation Blood 1999 94: 1465–1470

    CAS  PubMed  Google Scholar 

  35. Miyoshi H, Tanaka-Taya K, Nagae Y et al. Cytomegalovirus retinitis after transplantation of positively selected CD34+ cells from HLA-mismatched donors Pediatr Infect Dis J 1998 17: 345–348

    Article  CAS  Google Scholar 

  36. Holmberg LA, Boeckh M, Hooper H et al. Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation Blood 1999 94: 4029–4035

    CAS  PubMed  Google Scholar 

  37. Martinez C, Urbano-Ispizua A, Rozman C et al. Immune reconstitution following allogeneic peripheral blood progenitor cell transplantation: comparison of recipients of positive CD34+ selected grafts with recipients of unmanipulated grafts Exp Hematol 1999 27: 561–568

    Article  CAS  Google Scholar 

  38. Osawa M, Hanada K, Hamada H, Nakauchi H . Long-term lymphohematological reconstitution by a single CD34 low/negative hematopoietic stem cell Science 1996 273: 242–245

    Article  CAS  Google Scholar 

  39. Goodell MA, Rozenzweig M, Kim H et al. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable level of CD34 antigen exist in multiple species Nature Med 1997 3: 1337–1345

    Article  CAS  Google Scholar 

  40. Morel F, Galy A, Chen B, Szilvassy SJ . Equal distribution of competitive long-term repopulating stem cells in the CD34+ and CD34 fractions of Thy 1 low Lin low Sca1+ bone marrow cells Exp Hematol 1998 26: 440–448

    CAS  PubMed  Google Scholar 

  41. Sato T, Laver JH, Ogawa M . Reversible expression of CD34+ by murine hematopoietic stem cells Blood 1999 94: 2548–2554

    CAS  PubMed  Google Scholar 

  42. Zanjani ED, Almeida-Porada G, Livingston AG et al. Human bone marrow CD34 cells engraft in vivo and undergo multilineage expression that includes giving rise to CD34+ cells Exp Hematol 1998 26: 353–360

    CAS  PubMed  Google Scholar 

  43. Bhatia M, Bonnet D, Murdoch B et al. A newly discovered class of human hematopoietic cells with SCID-repopulating activity Nature Med 1998 4: 1038–1045

    Article  CAS  Google Scholar 

  44. Nakauchi Y . Hematopietic stem cells: are they CD34-positive or CD34-negative? Nature Med 1998 4: 1009–1010

    Article  CAS  Google Scholar 

  45. Nakamura Y, Ando K, Chargui J et al. Ex vivo generation of CD34+ cells from CD34 hematopoietic cells Blood 1999 94: 4053–4059

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported in part by the Grant-in-Aid for Cancer Research (10-1) from the Ministry of Health and Welfare of Japan. The authors thank Mr Toshiaki Tanaka, Dr Adam Tucker, Dr Yasuo Haruki and Ms Mari Sato for their assistance in statistical analysis and preparation of the manuscript.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kato, S., Yabe, H., Yasui, M. et al. Allogeneic hematopoietic transplantation of CD34+ selected cells from an HLA haplo-identical related donor. A long-term follow-up of 135 patients and a comparison of stem cell source between the bone marrow and the peripheral blood. Bone Marrow Transplant 26, 1281–1290 (2000). https://doi.org/10.1038/sj.bmt.1702707

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702707

Keywords

This article is cited by

Search

Quick links